Full notification file
General informationNotification NumberB/DE/10/PEI1279Member State to which the notification was sentGermanyDate of acknowledgement from the Member State Competent Authority02/02/2011Title of the ProjectTK008: Randomized phase III trial of haploidentical HCTwith or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemiaProposed period of release:01/11/2012 to 30/11/2015Name of the Institute(s) or Company(ies)MolMed SpA, Via Olgettina 558 20132
Milano (Italy);
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:Murine cell with MCH=H-2q haplotype. The cells are obtained from ATCC (ATCC cat # CRL
9641Information relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | mouse | mus | musculus | | NIH Swiss | |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known